Encephalitis in a Ghanian man  by Framm, Stuart R. et al.
Case Reportfrom The New York-New Jersey Intercity Infectious Disease Rounds 
Edited by Donald B. Louria, MD 
Encephalitis in a Ghanian Man 
Stuart R. Framm, MD;* Holly M. Gilbert, MD;* and John L. Ho, MD* 
A 32-year-old Ghanian man presented on July 7, 1995, 
to another hospital, after noting a worm in his con- 
junctiva. A peripheral blood smear revealed microfi- 
lariae, and he was given diethylcarbamazine (DEC). He 
did not take the medication until August 12, and after 
two doses he became somnolent, progressively unre- 
sponsive, and was febrile to 102°F (38.9”C). He was 
hospitalized, found to have a white blood cell (WBC) 
count of 11 X 103/mm3 with 39% eosinophils (eos.), 
and was started on intravenous antibiotics and pred- 
nisone. A computed tomographic (CT) scan of the head 
was unremarkable; cerebrospinal fluid (CSF) was 
notable for a WBC count of 10O/l~,L; and microfilariae 
were seen in the CSE He continued to be lethargic and 
was transferred to The New York Hospital-Cornell Med- 
ical College on August 30 for further management. 
The patient was born in Ghana and had lived in 
the United States for 3 years. He lived in Gabon from 
1988 to 1990, where he worked in a forested area and 
had many insect bites. Physical examination showed 
the patient to be afebrile. He had sharp fundi bilater- 
ally, his lungs were clear to auscultation, cardiac exam- 
ination revealed no murmurs, and his abdominal 
examination was normal. The patient was lethargic but 
arousable. He was oriented to name and place only and 
could follow only simple commands. He had normal 
strength and sensation, but walked with a wide-based 
gait and frontal release signs were noted. Babinski 
reflexes were not present. 
On admission, the WBC count was 7.2 X 103/mm3 
(0.6% eos.) and CSF results were as follows: 2 WBC/yL, 
51 red blood cells (RBC)/P,L, glucose 73 mg/dL, protein 
47 mg/dL; no bacteria or polymorphonuclear neu- 
trophils (PMNs) were seen on Gram stain. A CT scan 
of the head was unremarkable. The peripheral blood 
smear, from blood drawn during the day (Figure l), 
and CSF (Figure 2) both revealed microfilariae. 
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The patient was started on DEC in escalating doses 
(up to 650 mg/day) along with prednisone (20 mg 
orally three times a day) for a total of 21 days. He did 
well following treatment, with complete resolution of 
his altered mental status, and he returned to work. 
DIFFERENTIAL DIAGNOSIS 
This patient’s clinical presentation may have been a result 
of the neurotoxic effects of microfilariae, of a reaction to 
the killing of the microfilariae, known as the Mazzotti 
reaction, or of a direct toxic effect of DEC. Filarial nema- 
todes that should be considered include: Onchocercu 
volvulus, Wuchereria bancrofi, Brugia malayi, and Loa 
loa. 
Onchocerca VOZVUZUS is a filarial nematode that 
affects the eye. The ocular pathology is caused by an 
immune response to the microfilarial antigens. The 
microfilariae of Onchocerca are unsheathed; they are not 
found in the peripheral blood; and the adult worm is not 
seen in the eye. Wuchereria bancrofti is sheathed, but 
does not involve the eye, and the microfilariae are found 
in the peripheral blood at night. Brugia malayi is also 
sheathed, but this nematode is found in Indonesia and 
Asia, not in Africa. 
Differential diagnosis of the eye involvement 
included: (1) Wuchereriu bancrofti infection, (2) Loa 
Zoa infection, (3) Brugia malayi infection, and (4) 
Onchocerca VOZVUZUS infection. Differential diagnosis of 
the lethargy included: (1) filarial infection alone, (2) toxic 
effect of DEC, and (3) Mazzotti reaction. 
Figure 1. Sheathed microfilaria in peripheral blood smear. 
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Figure 2. Sheathed microfilaria in cerebrospinal fluid. 
DIAGNOSIS 
Loa Zoa infection with encephalitis. 
DISCUSSION 
Loa Zoa is a filarial nematode transmitted to humans by 
the tabanid fly (or African red fly) and is endemic to the 
African equatorial ram forest. The adult worm migrates 
through subcutaneous tissues causing localized, recurrent, 
subcutaneous edema, called Calabar swellings. It can also 
migrate through the subconjunctiva, causing conjunc- 
tivitis. Other less common manifestations include: 
endomyocardial fibrosis, retinopathy, peripheral neuro- 
pathy, arthritis, pleural effusions, breast calcifications, 
immune complex nephropathy, and encephalopathy. The 
sheathed microfilariae of Loa Zoa are seen in the peri- 
pheral blood during the day. 
Encephalitis has been documented with Loa Zoa infec- 
tion, usually in patients with a high degree of micro- 
filaremia who are treated with DEC.‘,’ It is unclear whether 
the symptoms are due to the neurotoxic effect of the live 
microfilariae,2 to a Mazzotti-type reaction to the dying 
microfilariae,‘~* or to a direct side effect of DEC.‘,’ 
The prevalence of microfilariae in the CSF of patients 
infected with Loa Zoa is not known, but has been doc- 
umented in some patients with neurologic symptoms. 
The pathology causing the neurologic manifestations seen 
when treating Loa Zoa is not fully understood. Microfi- 
lariae are seen in fibrin thrombi occluding small vessels, 
which may lead to cerebral ischemia.’ These thrombi 
may be caused by the accumulation of immune com- 
plexes formed when antigens are released or exposed as 
DEC deteriorates the outer cuticle of the microfilariael 
Another proposed mechanism of the neurologic seque- 
lae is that the inner body of the microfilariae may con- 
tain direct neurotoxins, but this has not been proven in 
filarial infecti0ns.l 
A Mazzotti reaction is an immune-mediated response 
to the sudden killing of large numbers of microfilariae; 
the symptoms range from mild to life-threatening, and 
include intense pruritus, rash, fever, lymphadenopathy, 
arthalgias, eosinophilia, and hypotension.3s4 The side 
effects of DEC include headache, dizziness, fatigue, nau- 
sea, vomiting, skin rash, facial edema, pruritus, and 
encephalitis; and these may also have contributed to this 
patient’s symptoms3 Although the conventional inter- 
pretation of these symptoms has been that they are 
caused by the direct toxic effects of DEC, some may be 
due to release of toxic components of the microfilariae 
of Loa Zoa. 
The critical dose of DEC is between 25 and 50 mg/ 
day, because this dose markedly reduces microfilaremia.’ 
The recommendations for patients with a high microfi- 
larial load (> 5O,OOO/mL) include starting DEC therapy at 
a low dose and gradually increasing the dose, along with 
antihistamines and steroids1 Corticosteroids are used 
to decrease the inflammatory response to the dying micro- 
filariae and are recommended in patients with high 
microfilarial loads to decrease the risk of neurologic com- 
plications.lz5 The above protocol does not prevent 
encephalitis in all patients, however, and some authors 
suggest discontinuing the DEC once neurologic symp- 
toms appear.l An alternative treatment in patients who 
have a high burden of microfilaremia is to use apheresis 
to decrease the microfilaremia prior to DEC treatment.5 
Editor’s Note: The diagnosis of Loa loa is clear. The cause of 
the lethargy is not. The prompt occurrence of lethargy after two 
doses of DEC indicates that it was DEC-related, a Mazzotti 
reaction, or both. In this case, the therapeutic approach of build- 
ing up to the final DEC dosage and use of steroids makes a 
great deal of sense. In patients with a high filarial load in peri- 
pheral blood, steroids should routinely be used with the DEC. 
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